Biden’s pick to lead the FDA might focus his attention on COVID-19, clinical trials and drug prices.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}